Viking Therapeutics, Inc.

10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Shareholder vote results May 26, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Feb 11, 2026 8-K Results of operations (earnings release) Feb 11, 2026 10-Q Quarter ended 2025-09-30 Oct 23, 2025 8-K Results of operations (earnings release) Oct 22, 2025 8-K Regulation FD disclosure Aug 19, 2025 10-Q Quarter ended 2025-06-30 Jul 23, 2025 8-K Results of operations (earnings release) Jul 23, 2025 8-K Shareholder vote results May 27, 2025 10-Q Quarter ended 2025-03-31 Apr 24, 2025 8-K Results of operations (earnings release) Apr 23, 2025 8-K Changed accountants; Other events Apr 23, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Mar 11, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 5, 2025 8-K Regulation FD disclosure Nov 4, 2024 10-Q Quarter ended 2024-09-30 Oct 23, 2024 8-K Results of operations (earnings release) Oct 23, 2024 10-Q Quarter ended 2024-06-30 Jul 24, 2024 8-K Results of operations (earnings release) Jul 24, 2024 8-K Regulation FD disclosure Jun 4, 2024 8-K Director or officer change; Shareholder vote results May 23, 2024 10-Q Quarter ended 2024-03-31 Apr 25, 2024 8-K Results of operations (earnings release) Apr 24, 2024 8-K Regulation FD disclosure Mar 26, 2024 8-K Other events Mar 4, 2024 8-K Entered a material agreement; Other events Mar 1, 2024 8-K Regulation FD disclosure Feb 27, 2024 10-K Fiscal year ended 2023-12-31 Feb 7, 2024 8-K Results of operations (earnings release) Feb 7, 2024 10-Q Quarter ended 2023-09-30 Oct 25, 2023 8-K Results of operations (earnings release) Oct 25, 2023 10-Q Quarter ended 2023-06-30 Jul 26, 2023 8-K Results of operations (earnings release) Jul 26, 2023 8-K Shareholder vote results Jun 14, 2023 8-K Amended charter or bylaws May 11, 2023